ABCB1 and cancer: Interestingly, the multidrug-resistant cell line NCI/ADR-RES, resistant to adriamycin and other P-glycoprotein substrates, was less sensitive to GSI1 than the other breast cancer cell lines tested and than most other cancer cell lines.